264 related articles for article (PubMed ID: 33672903)
21. Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.
Bugrysheva JV; Sue D; Gee JE; Elrod MG; Hoffmaster AR; Randall LB; Chirakul S; Tuanyok A; Schweizer HP; Weigel LM
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396541
[No Abstract] [Full Text] [Related]
22. Ecofriendly Biomolecule-Capped
Dolatabadi A; Noorbazargan H; Khayam N; Moulavi P; Zamani N; Asghari Lalami Z; Ashrafi F
Microb Drug Resist; 2021 Feb; 27(2):247-257. PubMed ID: 32635796
[No Abstract] [Full Text] [Related]
23. Enhanced Anti-Bacterial Activity Of Biogenic Silver Nanoparticles Synthesized From
Majoumouo MS; Sibuyi NRS; Tincho MB; Mbekou M; Boyom FF; Meyer M
Int J Nanomedicine; 2019; 14():9031-9046. PubMed ID: 31819417
[TBL] [Abstract][Full Text] [Related]
24. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
25. Phytosynthesis of Silver Nanoparticles Using
Reddy NV; Li H; Hou T; Bethu MS; Ren Z; Zhang Z
Int J Nanomedicine; 2021; 16():15-29. PubMed ID: 33447027
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.
Schweizer HP
Future Microbiol; 2012 Dec; 7(12):1389-99. PubMed ID: 23231488
[TBL] [Abstract][Full Text] [Related]
27. Efflux pump inhibitory activity of biologically synthesized silver nanoparticles against multidrug-resistant Acinetobacter baumannii clinical isolates.
Behdad R; Pargol M; Mirzaie A; Karizi SZ; Noorbazargan H; Akbarzadeh I
J Basic Microbiol; 2020 Jun; 60(6):494-507. PubMed ID: 32301139
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of cethromycin against Burkholderia pseudomallei and investigation of mechanism of resistance.
Mima T; Schweizer HP; Xu ZQ
J Antimicrob Chemother; 2011 Jan; 66(1):73-8. PubMed ID: 20965890
[TBL] [Abstract][Full Text] [Related]
29. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An
Niska K; Knap N; Kędzia A; Jaskiewicz M; Kamysz W; Inkielewicz-Stepniak I
Int J Med Sci; 2016; 13(10):772-782. PubMed ID: 27766027
[No Abstract] [Full Text] [Related]
30. Mechanisms of Resistance to Folate Pathway Inhibitors in
Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of BAL30072 against Burkholderia pseudomallei.
Mima T; Kvitko BH; Rholl DA; Page MG; Desarbre E; Schweizer HP
Int J Antimicrob Agents; 2011 Aug; 38(2):157-9. PubMed ID: 21596528
[TBL] [Abstract][Full Text] [Related]
32.
Palau M; Muñoz E; Gusta MF; Larrosa N; Gomis X; Gilabert J; Almirante B; Puntes V; Texidó R; Gavaldà J
Microbiol Spectr; 2023 Jun; 11(3):e0028023. PubMed ID: 37078875
[TBL] [Abstract][Full Text] [Related]
33. Modulation of antibiotic resistance and induction of a stress response in Pseudomonas aeruginosa by silver nanoparticles.
Markowska K; Grudniak AM; Krawczyk K; Wróbel I; Wolska KI
J Med Microbiol; 2014 Jun; 63(Pt 6):849-854. PubMed ID: 24623636
[TBL] [Abstract][Full Text] [Related]
34. In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei.
Perumal Samy R; Pachiappan A; Gopalakrishnakone P; Thwin MM; Hian YE; Chow VT; Bow H; Weng JT
BMC Infect Dis; 2006 Jun; 6():100. PubMed ID: 16784542
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei.
Puknun A; Kanthawong S; Anutrakunchai C; Nazmi K; Tigchelaar W; Hoeben KA; Veerman EC; Bolscher JG; Taweechaisupapong S
World J Microbiol Biotechnol; 2016 Feb; 32(2):33. PubMed ID: 26754671
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
37. Ecofriendly synthesis of silver and gold nanoparticles by Euphrasia officinalis leaf extract and its biomedical applications.
Singh H; Du J; Singh P; Yi TH
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1163-1170. PubMed ID: 28784039
[TBL] [Abstract][Full Text] [Related]
38. The antibiotics of choice for the treatment of melioidosis in Indian set up.
Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
[TBL] [Abstract][Full Text] [Related]
39. Evaluating New Compounds to Treat
Ross BN; Myers JN; Muruato LA; Tapia D; Torres AG
Front Cell Infect Microbiol; 2018; 8():210. PubMed ID: 30013953
[No Abstract] [Full Text] [Related]
40. Photocatalytic Protein Damage by Silver Nanoparticles Circumvents Bacterial Stress Response and Multidrug Resistance.
Shi T; Wei Q; Wang Z; Zhang G; Sun X; He QY
mSphere; 2019 May; 4(3):. PubMed ID: 31043515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
